| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 04/08/2004 | WO2003027068A3 Substituted amines for the treatment of neurological disorders |
| 04/08/2004 | WO2003018553A8 Oral antidiabetic agents |
| 04/08/2004 | US20040068115 Charge transport compositions and electronic devices made with such compositions |
| 04/08/2004 | US20040068109 Activated blood coagulation factor X inhibitor and also to such a pharmaceutical agent and particularly has an excellent activity by oral administration |
| 04/08/2004 | US20040067999 Carbazole derivatives and their use as neuropeptide y5 receptor ligands |
| 04/08/2004 | US20040067998 Oral administering |
| 04/08/2004 | US20040067997 Respiratory syncytial virus |
| 04/08/2004 | US20040067983 Corticotropin releasing factor moderator; analgesics; drug abruse, drug dependency; schizophrenia |
| 04/08/2004 | US20040067976 Compounds useful for treating Hepatitis C virus |
| 04/08/2004 | US20040067964 Antiinflammatory agents |
| 04/08/2004 | US20040067954 Benzoylpyridazines |
| 04/08/2004 | US20040067953 Combination therapy for treating, preventing or managing proliferative disorders and cancers |
| 04/08/2004 | US20040067939 Indole-3-carboxamides as glucokinase activators |
| 04/08/2004 | US20040067531 Methods of modulating protein tyrosine kinase function with substituted indolinone compounds |
| 04/08/2004 | US20040066135 Electronic devices made with electron transport and/or anti-quenching layers |
| 04/08/2004 | CA2751086A1 Process for preparing quinazoline rho-kinase inhibitors and intermediates thereof |
| 04/08/2004 | CA2500231A1 Pyridine derivatives as cb2 receptor modulators |
| 04/08/2004 | CA2500221A1 Substituted 3-(2,5 -disubstituted) pyridyl-4-aryl pyrroles for treating inflammatory diseases |
| 04/08/2004 | CA2497333A1 Pyrazole derivatives as reverse transcriptase inhibitors |
| 04/08/2004 | CA2495338A1 Pyrazole amides for treating hiv infections |
| 04/07/2004 | EP1404669A2 Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases |
| 04/07/2004 | EP1404653A1 Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion |
| 04/07/2004 | EP1404337A2 QUINAZOLINE AND PYRIDO 2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7 |
| 04/07/2004 | EP1404325A2 Method for treating nerve injury caused by surgery |
| 04/07/2004 | EP1404321A1 1-alkyl-2-aryl-benzimidazole derivatives, their use for producing medicaments and pharmaceutical preparations containing said derivatives |
| 04/07/2004 | EP1189692B1 Novel triazine-based detoxification agents and their use |
| 04/07/2004 | CN1487933A Pyrazole compounds useful as protein kinase inhibitors |
| 04/07/2004 | CN1487932A New process for the preparation of the anti-migraine drug |
| 04/07/2004 | CN1487931A Naphthostyrils compounds |
| 04/07/2004 | CN1487920A Deltal-pyrrolines used as pesticides |
| 04/07/2004 | CN1487919A New mandelic acid derivatives and their use as throbin inhibitors |
| 04/07/2004 | CN1487831A Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mGluR1 antagonists |
| 04/07/2004 | CN1144793C Polar-substituted hydrocarbons |
| 04/07/2004 | CN1144791C Triazole compounds and its application as dopamine-D3-ligands |
| 04/07/2004 | CN1144788C Bicycle vasporession agonists |
| 04/07/2004 | CN1144587C Agents for relieving side effects |
| 04/06/2004 | US6716991 Process for preparing a substituted pyrazolyl benzenesulfonamide for the treatment of inflammation |
| 04/06/2004 | US6716881 Carbanilides used as pesticides |
| 04/06/2004 | US6716871 Cyclic AMP-specific phosphodie sterase inhibitors |
| 04/06/2004 | US6716870 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 04/06/2004 | US6716869 N-(2-(1-amidinopyrrol-3-yl)ethyl)-5,6-dihydroxy-1-(2-(2-methox y-3-sulfatopropionylamino)-3-chloro-4-methylvaleroyl)indole-2-carboxamide |
| 04/06/2004 | US6716866 Aryl-benzimidazole compounds having antiinfective activity |
| 04/06/2004 | US6716851 Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators or caspases and inducers of apoptosis and the use thereof |
| 04/06/2004 | US6716849 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect |
| 04/06/2004 | US6716843 Inhibitor of dipeptidyl-peptidase iv |
| 04/06/2004 | US6716841 Nitrogen containing heterobicycles as factor Xa inhibitors |
| 04/06/2004 | US6716840 Agonists of the melanocortin-4 receptor (?mc-4r?); useful treating obesity and type 2 diabetes |
| 04/06/2004 | US6716837 Heterocyclic compounds for the treatment of migraine |
| 04/06/2004 | US6716831 2,4-diamino-pyrimidine deprivatives having anti-cell proliferative activity |
| 04/06/2004 | US6716628 Chondrogenesis promoters and indolin-2-one derivatives |
| 04/06/2004 | US6716605 Indole derivatives having an antiviral activity |
| 04/06/2004 | CA2124306C Quinazolinone derivatives |
| 04/01/2004 | WO2004027378A2 Luminescence-based methods and probes for measuring cytochrome p450 activity |
| 04/01/2004 | WO2004026858A1 Substituted heterocyclylpyrimidines |
| 04/01/2004 | WO2004026846A1 Dna-targeted benzotriazine 1,4-dioxides and their use in cancer therapy |
| 04/01/2004 | WO2004026844A1 Methods and compositions of novel triazine compounds |
| 04/01/2004 | WO2004026843A1 Benzodiazepine derivatives and pharmaceutical compositions containing them |
| 04/01/2004 | WO2004026829A2 Heterocyclically substituted indolinones and their use as receptor tyrosine kinase inhibitors |
| 04/01/2004 | WO2004026828A1 Pyrrole derivatives as antimycobacterial compounds |
| 04/01/2004 | WO2004026822A2 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 04/01/2004 | WO2004026264A2 Novel aromatic compounds possessing antifungal or antibacterial activity |
| 04/01/2004 | WO2004026237A2 Compounds for the treatment of premature ejaculation |
| 04/01/2004 | WO2004026236A2 Cyclopentyl indole derivatives |
| 04/01/2004 | WO2004011439A3 Aryl substituted benzimidazoles and their use as sodium channel blockers |
| 04/01/2004 | WO2004006934A3 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours |
| 04/01/2004 | WO2004006352A3 Electronic devices made with electron transport and/or anti-quenching layers |
| 04/01/2004 | WO2003099771A3 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases |
| 04/01/2004 | WO2003099284B1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 04/01/2004 | WO2003008410A8 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression |
| 04/01/2004 | WO2002102314A3 Purine inhibitors of phosphodiesterase (pde) 7 |
| 04/01/2004 | WO2002098852A8 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins |
| 04/01/2004 | US20040063955 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines |
| 04/01/2004 | US20040063946 Jnk inhibitor |
| 04/01/2004 | US20040063942 Spiro-indolines as Y5 receptor antagonists |
| 04/01/2004 | US20040063935 Aliphatic nitrogenous five-membered ring compounds |
| 04/01/2004 | US20040063773 Adminstering a pyrrole substituted 2-indolinone compound to a human for the treatment of protein kinase related cellular disorders such as cancer, autoimmune disorders, diabetes, rheumatoid arthritis, angiogenesis and osteoarthritis |
| 04/01/2004 | US20040063772 1-(4-fluoro-3-cyanophenyl)-3-trifluoromethyl-5-pyrazolecarboxylic acid, 1-(4-fluoro-3-cyanophenyl)-3-trifluoromethyl-5-(2-furyl)pyrazole, and imidazole |
| 04/01/2004 | US20040063768 Cyclopentylindole derivatives are useful for the treatment of depression, attention deficit hyperactivity disorder, obsessive-compulsive disorder, post-trauma stress, substance abuse and sexual disorders |
| 04/01/2004 | US20040063765 Modulation of pathogenicity |
| 04/01/2004 | US20040063744 Such as 1-(4-(1-bromo-1-phenyl-methylene)-piperidin-1-yl)-2-(4,7-dimethoxy-6 -azaindol-3-yl)-ethane-1,2-dione for treatment of HIV and acquired immune deficiency syndrome |
| 04/01/2004 | US20040063737 CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agents |
| 04/01/2004 | US20040063735 Calcitonin gene related peptide receptor antagonists |
| 04/01/2004 | US20040063733 Quinazoline derivatives |
| 04/01/2004 | US20040063720 Tyrosine kinase inhibitors |
| 04/01/2004 | US20040063709 Acute and chronic inflammatory disorders; cancer |
| 04/01/2004 | US20040063705 Substituted pyrimidinyl derivatives and methods of use |
| 04/01/2004 | US20040063700 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 04/01/2004 | US20040063693 5-HT2A receptor related disorders; such as 1-(2-(2-fluoro-4-nitrophenoxy)ethyl)-3-(1piperazinyl)-2(1H)-pyrazinone |
| 04/01/2004 | US20040063691 Preparation and use of imidazole derivatives for treatment of obesity |
| 04/01/2004 | US20040063645 Such as ((2-(3-guanidino-2-hydroxy-propylcarbamoyl)-1H-indol-5-yl)-amide) |
| 04/01/2004 | DE10243939A1 Pyrroline Pyrrolines |
| 04/01/2004 | CA2768674A1 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 04/01/2004 | CA2499964A1 Methods and compositions of novel triazine compounds |
| 04/01/2004 | CA2499701A1 Pyrrole derivatives as antimycobacterial compounds |
| 04/01/2004 | CA2498781A1 Indolinones substituted by heterocycles, their preparation thereof and their use as medicaments |
| 04/01/2004 | CA2497560A1 Luminescence-based methods and probes for measuring cytochrome p450 activity |
| 04/01/2004 | CA2496306A1 Substituted heterocyclylpyrimidines |
| 03/31/2004 | EP1403269A1 Remedial agent for viral infectious disease |
| 03/31/2004 | EP1403255A1 Rho KINASE INHIBITORS |
| 03/31/2004 | EP1401832A1 High molecular weight hydroxyphenylbenzotriazole uv-absorbers for thin film applications |